Adhera Therapeutics, Inc. License Agreements
15 Contracts & Agreements
- Second Addendum to the License Agreement (Filed With SEC on August 4, 2022)
- Addendum to License Agreement Adhera Therapeutics, Inc. and Melior Pharmaceuticals I, LLC dated August 20, 2021 dated February 16, 2022 (Filed With SEC on April 15, 2022)
- License Agreement between Adhera Therapeutics, Inc. and Melior Pharmaceuticals I, LLC dated August 20, 2021 (Filed With SEC on April 15, 2022)
- License Agreement (Filed With SEC on August 4, 2021)
- License Agreement dated July 17, 2017 between Marina Biotech, Inc. and Oncotelic, Inc (Filed With SEC on November 13, 2017)
- AMENDMENT No. 2 to LICENSE AGREEMENT (Filed With SEC on May 14, 2015)
- INTELLECTUAL PROPERTY LICENSE AGREEMENT (Filed With SEC on November 14, 2012)
- AMENDMENT NO. 1TO RESEARCH AND LICENSE AGREEMENT (Filed With SEC on October 10, 2012)
- EXCLUSIVE LICENSE AGREEMENT (Filed With SEC on March 26, 2012)
- LICENSE AGREEMENT (Filed With SEC on February 22, 2012)
- RESEARCH AND LICENSE AGREEMENT (Filed With SEC on May 16, 2011)
- FIRST AMENDMENT DATED AS OF JANUARY 29, 2009 TO DEVELOPMENT AND LICENSE AGREEMENT BY AND BETWEEN AMYLIN PHARMACEUTICALS, INC. AND MDRNA, INC. (formerly Nastech Pharmaceutical... (Filed With SEC on August 12, 2010)
- NON-EXCLUSIVE PATENT LICENSE AGREEMENT (Filed With SEC on May 15, 2009)
- EX-10.1: PRODUCT DEVELOPMENT AND LICENSE AGREEMENT (Filed With SEC on February 2, 2006)
- EXCLUSIVE DEVELOPMENT, COMMERCIALIZATION AND LICENSE AGREEMENT (Filed With SEC on September 30, 2004)
